Mar 14, 2024 / 12:30PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
I'm pleased to welcome Bristol-Myers Squibb to the stage. My name is Carter Gould. I cover U.S. biopharma here. I'm pleased to welcome Lynelle Hoch, President, Cell Therapy Organization for Bristol; as well as Wendy Short Bartie, who runs the Hematology and Oncology business. Welcome both. Thank you very much for joining us today.
Unidentified Company Representative -
Thank you, Carter.
Questions and Answers:
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior AnalystAll right. Great. So obviously, we've got a big day tomorrow -- a big day today in terms of (inaudible) approval, but a big day tomorrow in terms of BCMA outcome. Briefing documents came out yesterday. Maybe Lynelle, just start with sort of your takeaways from the documents. Anything that surprised you and your level of confidence at this point?
Lynelle B. Hoch - Bristol-Myers Squibb Company - President of Cell Therapy Organization